Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment
Published 2013 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Toxicity and efficacy evaluation of multiple targeted polymalic acid conjugates for triple-negative breast cancer treatment
Authors
Keywords
-
Journal
JOURNAL OF DRUG TARGETING
Volume 21, Issue 10, Pages 956-967
Publisher
Informa UK Limited
Online
2013-09-16
DOI
10.3109/1061186x.2013.837470
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- In Vivo Delivery of Morpholino Oligos by Cell-Penetrating Peptides
- (2013) Hong M. Moulton CURRENT PHARMACEUTICAL DESIGN
- Gene Correction of a Duchenne Muscular Dystrophy Mutation by Meganuclease-Enhanced Exon Knock-In
- (2013) Linda Popplewell et al. HUMAN GENE THERAPY
- Distinct mechanisms of membrane permeation induced by two polymalic acid copolymers
- (2012) Hui Ding et al. BIOMATERIALS
- Two-in-one: combined targeted chemo and gene therapy for tumor suppression and prevention of metastases
- (2012) Min Zhang et al. Nanomedicine
- Nanobiopolymer for Direct Targeting and Inhibition of EGFR Expression in Triple Negative Breast Cancer
- (2012) Satoshi Inoue et al. PLoS One
- The optimization of polymalic acid peptide copolymers for endosomolytic drug delivery
- (2011) Hui Ding et al. BIOMATERIALS
- Polymalic Acid–Based Nanobiopolymer Provides Efficient Systemic Breast Cancer Treatment by Inhibiting both HER2/neu Receptor Synthesis and Activity
- (2011) Satoshi Inoue et al. CANCER RESEARCH
- EGFR-targeted stearoyl gemcitabine nanoparticles show enhanced anti-tumor activity
- (2011) Michael A. Sandoval et al. JOURNAL OF CONTROLLED RELEASE
- EGFR expression correlates with decreased disease-free survival in triple-negative breast cancer: a retrospective analysis based on a tissue microarray
- (2011) Donggen Liu et al. MEDICAL ONCOLOGY
- A Neutralizing RNA Aptamer against EGFR Causes Selective Apoptotic Cell Death
- (2011) Carla Lucia Esposito et al. PLoS One
- Effect of Surface-Immobilized Heparin on the Activation of Adsorbed Factor XII
- (2010) Graciela Elgue et al. ARTIFICIAL ORGANS
- Single and repeated dose toxicity of mesoporous hollow silica nanoparticles in intravenously exposed mice
- (2010) Tianlong Liu et al. BIOMATERIALS
- Triple negative breast cancer: unmet medical needs
- (2010) Sumanta Kumar Pal et al. BREAST CANCER RESEARCH AND TREATMENT
- Ambiguities in applying traditionalLimulusAmebocyte Lysate tests to quantify endotoxin in nanoparticle formulations
- (2010) Marina A Dobrovolskaia et al. Nanomedicine
- Multifunctional Tumor-Targeted Polymer-Peptide-Drug Delivery System for Treatment of Primary and Metastatic Cancers
- (2010) Pooja Chandna et al. PHARMACEUTICAL RESEARCH
- Inhibition of brain tumor growth by intravenous poly( -L-malic acid) nanobioconjugate with pH-dependent drug release
- (2010) H. Ding et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Local restoration of dystrophin expression with the morpholino oligomer AVI-4658 in Duchenne muscular dystrophy: a single-blind, placebo-controlled, dose-escalation, proof-of-concept study
- (2009) Maria Kinali et al. LANCET NEUROLOGY
- The Implications of Stochastic Synthesis for the Conjugation of Functional Groups to Nanoparticles
- (2008) Douglas G. Mullen et al. BIOCONJUGATE CHEMISTRY
- The biocompatibility of mesoporous silicates
- (2008) Sarah P. Hudson et al. BIOMATERIALS
- Poly(malic acid) nanoconjugates containing various antibodies and oligonucleotides for multitargeting drug delivery
- (2008) Julia Y Ljubimova et al. Nanomedicine
- Nanoconjugate based on polymalic acid for tumor targeting
- (2007) Julia Y. Ljubimova et al. CHEMICO-BIOLOGICAL INTERACTIONS
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started